Related Experiment Videos
[Studies on flomoxef in the perinatal period]
1Department of Obstetrics and Gynecology, Showa University, Fujigaoka Hospital.
The Japanese Journal of Antibiotics
|June 1, 1991
Summary
Flomoxef (FMOX) demonstrates excellent effectiveness and safety for treating perinatal infections in pregnant women. This antibiotic shows good penetration into fetal tissues and amniotic fluid, exceeding minimum inhibitory concentrations against common pathogens.
Area of Science:
- Perinatal medicine
- Infectious diseases
- Pharmacology
Background:
- Perinatal infections pose significant risks to mothers and newborns.
- Limited antibiotic options are available for safe use during pregnancy and childbirth.
- Flomoxef (FMOX) is a potential therapeutic agent for perinatal infections.